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By immunoprecipitation analysis using antisera against oligo peptides synthesized based on the deduced N-terminal and
C-terminal amino acid sequences of the SH proteins of the mumps virus, the SH protein was detected in mumps virus-
infected cells. The SH protein expressed from cDNA by the vaccinia-T7 expression system was recovered in the membrane
fraction. Association of the SH protein with the membrane was resistant to high salt, EDTA, and alkaline treatment but
sensitive to detergents. Indirect immunofluorescence experiments showed that the SH protein is involved in the exocytotic
pathway. These data indicate that the SH protein is a membrane protein. Treatment of microsomes with TPCK-trypsin
suggested that the SH protein is oriented in the membrane with its C-terminal facing the cytoplasm. Furthermore the SH
protein was not detected in a particular strain (Enders strain) of mumps virus, indicating that the mumps virus SH protein
is not essential for virus replication. q 1996 Academic Press, Inc.
INTRODUCTION SH protein has not been detected in MuV infected cells
(reviewed in Lamb and Kolakofsky, 1996, Takeuchi et al.,
Mumps virus (MuV), a member of the genus Rublavirus unpublished results). On the other hand, the SV5 SH
in the family Paramyxoviridae, contains a single-stranded protein of 44 amino acids was detected in SV5-infected
and negative-sense 50S RNA as a genome (Wolinsky, cells (Hiebert et al., 1985) and shown to be a membrane
1996). The gene order on the 50S genomic RNA is 3*- protein exposing its N-terminal to the cytoplasmic face
NP-P/V-M-F-SH-HN-L-5* (Elango et al., 1988) and the and its C-terminal to the cell surface (Hiebert et al., 1988).
complete nucleotide sequence consisting of 15,384 nu- In order to analyze possible functions of the SH gene
cleotides has been determined (Okazaki et al., 1992). in MuV replication, tissue tropism and viral pathogenesis,
A small gene between the F and HN genes was first we attempted to detect the SH protein in MuV-infected
identified in the simian virus 5 (SV5) and named ‘‘SH’’ cells. In this report, we describe the identification of the
because of the small and hydrophobic nature of the pre- SH protein in MuV-infected cells and experiments which
dicted protein (Hiebert et al., 1985), and the correspond- show that MuV SH protein is a membrane protein. We
ing gene was found later in MuV (Elango et al., 1989). also discuss the necessity of the SH protein in MuV
Among the Paramyxovirinae only SV5 and MuV have SH replication.
genes, although closely related viruses such as human
MATERIALS AND METHODSparainfluenza type 2 (PIV2) (Kawano et al., 1990), human
parainfluenza type 4 (PIV4) (Bando et al., 1990), and sim- Cells and viruses
ian virus 41 (SV41) (Tsurudome et al., 1991) have no such
HeLa cells and a stable line of HeLa cells that expressgene. Sequence analyses of the SH genes of MuV strains
the human CD4 molecule (HeLaT4) (Maddon et al., 1986)showed that MuV SH genes are hypervariable and that
were grown in Eagle’s minimum essential mediumthe nucleotide sequences of the gene could be useful in
(EMEM) supplemented with 10% fetal calf serum at 377identifying strains (Takeuchi et al., 1991, Turner et al.,
in 5% CO2 . Vaccinia recombinant virus vTF7.3 that ex-1991, Yeo et al., 1993, Afzal et al., 1993, Ku¨nkel et al.,
presses bacteriophage T7 RNA polymerase (Fuerst et1994, 1995). The MuV SH gene encodes a small open
al., 1986) was obtained from Dr. Bernard Moss of thereading frame of 57 amino acids and has functional gene
National Institutes of Health, Bethesda, Maryland. Thestart and stop sequences. A monocistronic SH mRNA
attenuated MuV vaccine Miyahara (MI), the Vero cell-was shown to be transcribed from genomic RNA by MuV
adapted Enders (ED), and the SBL-1 (SBL) (obtained fromRNA dependent RNA polymerase (Elango et al., 1989).
Dr. Komada, Mie University, Japan) strains were propa-These observations, taken together, predict the synthesis
gated as described previously (Takeuchi et al., 1988).of SH protein. However, in spite of several efforts, MuV
Construction of cDNAs encoding the SH protein
cDNA fragments encoding the SH genes were synthe-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /81-425-65-2498. E-mail: ktake@nih.go.jp. sized by the RT-PCR method using SH1 (5* TTG CAC
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times to shear chromosomal DNA, and diluted with 4
volumes of dilution buffer (1.25% Triton X-100, 190 mM
NaCl, 60 mM Tris-HCl (pH 7.4), 6 mM EDTA), followed
by incubation with antisera. SDS–polyacrylamide gel
electrophoresis (SDS–PAGE) was performed with a pre-
cast polyacrylamide gel SPU-15S (ATTO Corporation,
Tokyo, Japan) according to the manufacture’s protocol.
Sucrose flotation assayFIG. 1. Deduced amino acid sequences of the SH proteins of MI,
ED, and SBL strains. The positions of synthetic peptides T58, Y88, and
Flotation analyses were performed as described pre-S69 are boxed.
viously (Sanderson et al., 1994) with minor modification.
Briefly, cells were washed with PBS0 and hypotonic lysis
buffer containing 50 mM Tris–HCl (pH 7.4), 25 mM KCl,TAT GCC GGC GAT CC 3* ) and HN5 (5* GTG TTG TAT
and 5 mM MgCl2 and incubated with hypotonic lysisTGT GAT CCT AA 3* ) primers from total RNA extracted
buffer at 07 for 10 min. Cells removed from dishes byfrom MI-infected cells. The cDNA fragment digested by
scraping were disrupted by repeated passage (15 times)HindIII to remove HN gene regions was ligated to pSP72
through a 26-gauge hypodermic needle. Unbroken cellsplasmid DNA cut by SmaI and HindIII. The pGemSH was
and nuclei were removed by centrifugation (1000 g for 3constructed by excising the SH gene fragment from the
min) and the resulting postnuclear supernatant (0.2 ml)plasmid by EcoRI and HindIII and transferring it into
was mixed with 0.8 ml of 70% (wt/wt) sucrose in low-saltpGem3 cut by EcoRI and HindIII such that the SH genes
buffer (LSB) containing 50 mM Tris–HCl (pH 7.4), 25 mMare under control of T7 promoter. The minicistron of six
KCl, and 5 mM MgCl2 . The mixture was then overlaidamino acids before SH ORF found in the SH mRNA was
with 0.8 ml of 55% sucrose (wt/wt) sucrose in LSB andremoved to enhance the expression level of the protein.
0.2 ml of 10% (wt/wt) sucrose in LSB followed by centrifu-
Preparation of antisera gation at 50,000 rpm for approximately 16 hr at 47 by
using a TLS-55 swinging bucket rotor in a Beckman TLA-
The T58 peptide (NH2-PAIQPPLYPTFLLC-COOH), Y88 100 table-top ultracentrifuge. Following centrifugation,
peptide (NH2-CTYKTAVRHAALHQRSFSRWSLDHSL- 0.4-ml fractions were collected from the top of the gradi-
COOH), and S69 peptide (NH2-CNHKTAVRYAALYQRSCS- ent and were diluted with RIPA buffer prior to the immu-
RWGFDQSL-COOH) were synthesized (Fig. 1) and cou- noprecipitation.
pled to Keyhole limpet hemocyanin. Cysteine residues
at amino- and carboxy-termini were added for the malei- Trypsin treatment of microsomes
mido benzoyl-N-hydroxysuccinimide ester conjugation
HeLaT4 cells infected with vaccinia virus vTF7.3 andmethod. Immunization of rabbits was described pre-
transfected with pGemSH were labeled with [3H]leucineviously (Takeuchi et al., 1990).
for 30 min. The microsomes were prepared and digested
with 250 mg/ml of TPCK-trypsin for 2 hr in the presenceExpression of the SH proteins in eukaryotic cells
or absence of NP-40 essentially as described previously
For the vaccinia-T7 expression system, subconfluent (Paterson and Lamb, 1993).
HeLaT4 cells infected with vaccinia virus vTF7.3 as de-
scribed previously (Takeuchi and Lamb, 1994) were Immunofluorescence
transfected with pGem3 recombinant plasmid with Lipo-
For indirect immunofluorescence, HeLaT4 cells in-fectamine (Gibco BRL) according to the manufacturer’s
fected with vaccinia virus vTF7.3 and transfected withprotocol. Cultures were incubated for 5 hr at 377 in 5%
pGemSH were fixed in 4% paraformaldehyde in PBS andCO2 . MuV infection of HeLa cells was described pre- permeabilized by incubating in 0.2% Triton X-100 in PBSviously (Takeuchi et al., 1990).
for 5 min. Indirect immunofluorescence was done as de-
scribed previously (Paterson and Lamb, 1993) using Y88Metabolic labeling, immunoprecipitation, and
antiserum at (1:500).SDS–PAGE
Infected cells were washed twice with EMEM without RESULTS
L-leucine and incubated at 377 for 30 min. The cells were
Specificity of antisera against the SH protein
labeled with [3H]leucine (NEN, Wilmington, DE) as indi-
cated. Immunoprecipitations were done as described At first we have prepared two antisera (T58 and
Y88) against synthetic peptides as described underpreviously (Hiebert et al., 1988). Briefly, the lysate pre-
pared in 1% sodium dodecyl sulfate (SDS) was boiled for Materials and Methods. These antisera specifically
reacted with the respective peptides in ELISA (data5 min, passed through a hypodermic needle several
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FIG. 2. Expression of the SH protein in HeLaT4 cells by using the
FIG. 3. Immunoprecipitation of the SH protein expressed from cDNA.vaccinia-T7 expression system. (A) Cells infected with vaccinia virus
The SH protein expressed by vaccinia-T7 expression system was la-vTF7.3 and then transfected with pGem3 vector plasmid (lane 1) or
beled with [3H]leucine (lane 1) and immunoprecipitated with preimmunepGemSH (lane 2) were labeled with 20 mCi/ml of [3H]leucine. (B) Cells
serum (lane 2), antiserum against T58 peptide (lane 3), and antiseruminfected with vaccinia virus vTF7.3 and then transfected with pGem3
against Y88 peptide (lane 4). The precipitates were analyzed by SDS–(lane 1), pGemSH (lane 2), pGemV (lane 3), and pGemP (lane 4) were
PAGE. The position of the SH protein is indicated.labeled with 40 mCi/ml of 35S-Trans. Cells were lysed in SDS sample
buffer and analyzed by SDS–PAGE. The positions of P, V, and SH are
indicated.
kDa was detected with both T58 (lane 3) and Y88 (lane
4) antisera in MuV-infected cells but not in uninfected
cells (lanes 1 and 2). In addition to the SH protein, promi-not shown). To test the reactivity of these antisera with
the SH protein, a large amount of the SH protein was nent signals, which were thought to be from cellular pro-
teins, were observed in a relatively high-molecular-synthesized from cDNA using the vaccinia-T7 hybrid
expression system (Fuerst et al., 1986). Since the nu- weight region.
cleotide sequence of the SH gene predicted the pres-
ence of 11 leucine residues and 1 methionine residue, Membrane association of the SH protein
cells were labeled with [3H]leucine or 35S-Trans. The
It was reported that SH protein of SV5 is a membranecell lysates were resolved in a precast polyacrylamide
protein (Hiebert et al., 1988). To examine whether MuVgel for low-molecular-weight proteins (PAGEL, SPU-
SH protein is also a membrane protein, we employed15S). When the cells were labeled with [3H]leucine,
a subcellular fractionation scheme previously used toa small polypeptide with an approximate molecular
demonstrate the membrane association of the Sendaiweight of 6 kDa was detected in pGemSH-transfected
virus M protein (Sanderson et al., 1994). For this purpose,cells (Fig. 2A, lane 2) but not in the vector-transfected
the F, V, and SH proteins of MuV were expressed fromcells (Fig. 2A, lane 1). However, when the cells were
pGemF (Tanabayashi et al., unpublished results), pGemVlabeled with 35S-Trans, the SH protein was not de-
tected (Fig. 2B, lane 2), although the V (Fig. 2B, lane
3) and P (Fig. 2B, lane 4) proteins were labeled with
35S-Trans. It was probably because the initiator methi-
onine was removed by methionine amino peptidase,
since it precedes a small uncharged amino acid,
proline (Huang et al., 1987, Boissel et al., 1988,
Moerschell et al., 1990). We, therefore, used [3H]-
leucine to label the SH protein throughout the experi-
ments. As shown in Fig. 3, both T58 (lane 3) and Y88
(lane 4) antisera immunoprecipitated the SH protein
synthesized from cDNA, indicating that both antisera
could be used to search for the SH protein in MuV-
infected cells.
Expression of SH protein in MuV-infected cells
FIG. 4. Detection of SH protein in MuV-infected cells. The lysatesTo examine whether the SH protein is synthesized in
from uninfected HeLa cells (lanes 1 and 2) and MuV MI-infected cells
MuV-infected cells, [3H]leucine-labeled lysate from HeLa (lanes 3 and 4) labeled with 200 mCi/ml of [3H]leucine were immunopre-
cells infected with the MI strain was immunoprecipitated cipitated with antiserum against T58 peptide (lanes 1 and 3) or antise-
rum against Y88 peptide (lanes 2 and 4) and analyzed by SDS–PAGE.with antisera. As shown in Fig. 4, the SH protein of 6
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Localization of the SH protein by indirect
immunofluorescence
To further determine the subcellular localization of
the SH protein, indirect immunofluorescence analysis
was carried out using Y88 antiserum. When the cells
infected with vaccinia virus vTF7.3 and transfected
with pGemSH were fixed, permeabilized, and stained
as described under Materials and Methods, reticular
staining characteristic of ER and perinuclear Golgi
was detected (Fig. 7B). On the other hand, the control
cells infected with vaccinia virus vTF7.3 and trans-
fected with no plasmid did not show any staining (Fig.
FIG. 5. Sucrose density gradient analysis of F, V, and SH proteins.
7A). Surface staining of the SH protein with both T58HeLaT4 cells were infected with vaccinia virus vTF7.3 and then trans-
and Y88 antisera was unsuccessful (data not shown).fected with the plasmids indicated and labeled with 50 mCi/ml of [3H]-
leucine and disrupted. After sucrose gradient centrifugation, fractions These data indicate that the SH protein is involved in
were collected from the top and diluted with dilution buffer. The F an exocytotic pathway.
protein (A), V protein (B), and F protein (C) were recovered by immuno-
precipitation and analyzed by SDS–PAGE. Fractions are numbered
Orientation of the SH protein in the membranefrom the top (fraction 1) to the bottom (fraction 5).
It was reported that the SV5 SH protein is exposing
its N-terminal domain to the cytoplasm and its C-terminal
(Takeuchi et al., unpublished results), and pGemSH, re- domain to the cell surface (Hiebert et al., 1988). To exam-
spectively, using the vaccinia-T7 system. We used the V ine the orientation of the MuV SH protein in the mem-
protein as a negative control because the V protein was brane, we used the trypsin treatment of microsomes.
reported to be distributed throughout the cytoplasm of For this purpose, the SH protein was expressed from
infected cells (Curran et al., 1991; Wardrop and Briedis, pGemSH using the vaccinia-T7 system. When a crude
1991; Paterson et al., 1995). The postnuclear fraction was microsome was digested with TPCK-trypsin in the ab-
prepared and subjected to sucrose gradient centrifuga- sence of NP-40, the slightly more quickly migrating SH
tion as described under Materials and Methods. Frac- and a small amount of undigested SH were detected
tions after equilibrium centrifuge were collected, and the with T58 antiserum (Fig. 8, lane 2). A small amount of
F, V, and SH proteins were immunoprecipitated with an undigested SH was also detected with Y88 (Fig. 8, lane
anti-F monoclonal antibody mixture (Yamada et al., 1988), 5). When a crude microsome was digested with TPCK-
T60 antiserum against the V protein (Takeuchi et al., trypsin in the presence of NP-40, no signal was detected
1990), and Y88 antiserum, respectively. As shown in Fig. with either T58 (lane 3) or Y88 (lane 4) antisera. These
5, both the F and the SH proteins were recovered in data indicate that the C-terminal region of the SH protein
fraction 1 corresponding to the 10%/55% (wt/wt) sucrose
interface, suggesting that the SH protein was associated
with the cellular membrane. On the other hand, the V
protein was stayed in fraction 3 to 5 corresponding to
55% (wt/wt) to 70% (wt/wt) sucrose. We next attempted
to address the question whether the SH protein is a
peripheral protein that can be removed from a membrane
by extremes of pH and ionic strength and by chelating
divalent cations or if it is an integral protein which can
be released only by treatment with detergents (Chong
and Rose, 1993). Fraction 1 was then treated with 2 M
KCl, 50 mM EDTA, or pH 11 followed by the second
sucrose gradient centrifugation. The SH protein was re-
FIG. 6. Stability of SH protein association with membranes. Totalsistant to these treatments and recovered again in frac- cellular membranes containing the SH protein prepared as described
tion 1 (Fig. 6). On the other hand, treatment with 60 mM under Materials and Methods were treated with 2 M KCl–10 mM Tris–
octyl glucoside released the SH protein from the mem- HCl (pH 7.4), 50 mM EDTA–10 mM Tris–HCl (pH 7.4), carbonate buffer
(pH 11), and 60 mM octyl glucoside. Samples were mixed with 70%brane (Fig. 6). Treatments with NP-40, Triton X-100, and
(wt/wt) sucrose, and membranes were reisolated on a second sucroseChaps also released the SH protein from the membrane
flotation gradient. Fractions were collected, diluted with dilution buffer,
but at different efficiencies (data not shown). These find- immunoprecipitated with antiserum against Y88 peptide, and analyzed
ings indicate that the SH protein has the character of an by SDS–PAGE. Fractions are numbered from the top (fraction 1) to the
bottom (fraction 5).integral membrane protein.
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FIG. 7. Indirect fluorescent staining of the SH protein. HeLaT4 cells infected with vaccinia virus vTF7.3 and transfected with no plasmid (A) and
pGemSH (B) were fixed, made permeable, and stained with Y88 antisera and fluorescein isothiocyanate-conjugated goat anti-rabbit IgG.
is exposed outside of the microsome vesicles and is synthesized in ED-infected cells. Since the SH genes
are hypervariable, however, and there are one andsusceptible to digestion with TPCK-trypsin, leaving only
its N-terminal half. eight amino acid substitutions in regions correspond-
ing to the T58 peptide and the Y88 peptide, respec-
tively (Fig. 1), the S69 peptide corresponding to aminoThe SH protein synthesis in ED strain-infected cells
acid positions 33 to 57 of the ED SH protein (Fig. 1)
We previously reported that neither SH monocis- was synthesized and antiserum against this peptide
tronic nor SH-HN dicistronic mRNA was detected in was raised. S69 antiserum specifically reacted with
ED-infected cells, and the SH gene was exclusively S69 peptide (data not shown). As shown in Fig. 9, the
transcribed as F-SH dicistronic or F-SH-HN tricistronic SH protein was detected in SBL-infected cells (lane
mRNA (Takeuchi et al., 1988). This finding suggests 3), but not in ED-infected cells (lane 2). The SBL strain
the absence of the SH protein synthesis in ED-infected was used as a control, because both ED and SBL
cells, since according to the ribosome scanning model SH proteins have the same amino acid sequence in
(Kozak, 1991a), translation from a second cistron on positions 33 to 57 (Takeuchi et al., 1991; Elango et al.,
polycistronic mRNA without IRES (internal ribosome 1989; Elliot et al., 1989). The SH protein was not found
entry sequence) is unlikely to take place in eukaryotic even though the X-ray film was overexposed. The re-
cells. To see whether the SH gene of the ED strain sult clearly shows that there is no evidence of internal
directed the synthesis of the SH protein, we carried initiation of translation of the SH gene and that the SH
out a preliminary experiment using T58 and Y88 anti- protein is not synthesized in ED-infected cells.
sera. The result indicated that SH protein was not
FIG. 8. Trypsin treatment of microsomes. Crude microsomes pre- FIG. 9. Lack of SH protein synthesis in ED strain-infected cells.
Uninfected cells (lane 1), ED-infected cells (lane 2) SBL-infected cellspared from vaccinia virus vTF7.3-infected and pGemSH-transfected
cells were treated with TPCK-trypsin in the absence of NP-40 (lanes 2 (lane 3), and vaccinia virus vTF7.3 infected and pGemSH(ED) trans-
fected cells (lane 4) were labeled with [3H]leucine and lysed. The ly-and 5) or in the presence of NP-40 (lanes 3 and 6) or untreated (lanes
1 and 4). The samples were immunoprecipitated with T58 antiserum sates were immunoprecipitated with antiserum against S69 peptide
and analyzed by SDS–PAGE. The position of the SH protein is indi-(lanes 1 to 3) or Y88 antiserum (lanes 4 to 6) and subjected to SDS–
PAGE. The asterisk indicates a truncated SH protein. cated.
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DISCUSSION at least in tissue culture. It may not be surprising because
closely related viruses such as PIV2, PIV4, and SV41 do
By using SH-specific antisera and [3H]leucine for meta- not have a gene coding for an SH-like protein; neverthe-
bolic labeling as well as a precast polyacrylamide gel less, they can replicate in tissue culture as well as in their
designed for analyses of low-molecular-weight proteins, hosts. We reported previously that both tissue culture-
the previously unrecognized SH protein has been de- adapted and egg-adapted ED strains have the same
tected in MuV-infected cells. point mutation in the putative polyadenylation signal for
The amount of the SH protein in MuV-infected cells the F gene and that neither SH monocistronic mRNA nor
appeared relatively small. There is a minicistron of 6 SH-HN dicistronic mRNA was expressed in these cells
amino acids upstream of SH ORF starting at 4 to 6 nucle- (Takeuchi et al., 1991). It is thus possible that the expres-
otides and ending at nucleotides 19 to 21, numbered sion of the SH protein is not required for virus growth in
according to Elliott et al. (1989). This minicistron is well ovo. Interestingly, the same point mutations in the puta-
conserved in almost all MuV strains thus far sequenced tive polyadenylation signal for the F gene were reported
except one strain (Bristol strain) which has a T in place previously in the genomes of the vaccine strain Rubini
of an A at nucleotide 19, resulting in the loss of a termina- and the field isolate (Ch5/87) from a patient who devel-
tion codon, and has the potential to code for a 49-amino- oped meningitis in 1987 (Ku¨nkel et al., 1995). The muta-
acid polypeptide (Yeo et al., 1993). While the presence tion in these viruses would affect the transcription of the
of minicistron is known to severely reduce the translation F gene, resulting in F-SH read-through and a subsequent
efficiency of following cistron, it was reported that about lack of SH protein synthesis. It may be interesting to
half of ribosomes bypassed the first AUG codon and compare clinical signs shown by patients infected with
initiated at a downstream site when the first AUG is the Ch5/87 strain and other MuV strains, because there
within 12 nucleotides from the cap (Kozak, 1991b). It remains the possibility that a protein, like SH, probably
seems, therefore, likely that the presence of the minisis- dispensable for viral replication, may modify viral patho-
tron in SH mRNA is responsible for the reduced amount genesis in vivo as suggested for the C protein of VSV
of the SH protein, although the possibility that the effi- (Kretzschmar et al., 1996).
ciency of immunoprecipitation was not sufficiently high It has been reported that many viruses code for small
could not be ruled out. hydrophobic viral proteins such as the poliovirus 3A, HIV
The results of sucrose flotation analysis indicated that Vpu, influenza virus M2, influenza virus NB, togavirus 6K
MuV SH protein is a membrane protein. This result is in protein, RSV SH, the coronavirus D3, papillomavirus E5,
good agreement with the hydrophobic nature of the MuV and the adenovirus E3 proteins, and these proteins,
SH protein. Treatment of membranes with 60 mM octyl which modify or may modify membrane permeability,
glucoside efficiently released SH protein from mem- were proposed to be called viroporins (Carrasco, 1995).
branes; however, some SH protein was still bound to As MuV SH protein is shown to have the properties of a
membranes after extraction with Triton X-100, suggesting membrane protein, it seems likely that MuV SH protein
that the SH protein was associated with Triton X-100 also modifies membrane permeability as a viroporin.
insoluble lipids as reported previously (Sanderson et
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